IDH2 and acute myeloid leukemia: Of note, for both Menin and IDH inhibitors (see below), the induction of differentiation and a so‐called “differentiation syndrome” can be seen, further implicating aberrant epigenetic regulation in LSC as driving the differentiation block apparent in AML.